| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.21 | 0.1 |